Issei Tsukamoto, SVP, Head of Business Development, Astellas Pharma Inc.
Advertisement
Articles by Issei Tsukamoto, SVP, Head of Business Development, Astellas Pharma Inc.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
2
Articulating the Long-Term Value of AI-Powered Approaches
3
Hims & Hers Pulls Access to Compounded Semaglutide Pill Following Controversial Launch
4
TrumpRx Is Live and Complicated
5